CVS Health Corp (CVS)
NYSE:CVS
Want to see CVS full AI Analyst Report?
CVS Stock Chart & Stats
$77.30
-$0.04(-0.09%)
At close: 4:00 PM EST
$77.30
-$0.04(-0.09%)
Day’s Range― - ―
52-Week Range$58.50 - $102.77
Previous CloseN/A
Volume5.40M
Average Volume (3M)8.78M
Market Cap
$125.45B
Enterprise Value$195.32B
Total Cash (Recent Filing)$11.80B
Total Debt (Recent Filing)$78.34B
Price to Earnings (P/E)42.7
Beta0.54
Next Earnings
Aug 05, 2026EPS Estimate
1.83Next Dividend Ex-DateN/A
Dividend Yield3.41%
Share Statistics
EPS (TTM)2.31
Shares Outstanding1,275,927,200
10 Day Avg. Volume8,687,216
30 Day Avg. Volume8,782,641
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market Cap1.56
Enterprise Value/Revenue0.48
Enterprise Value/Gross Profit3.45
Enterprise Value/Ebitda17.55
Forecast
1Y Price Target
$104.53Price Target Upside35.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
EPS Forecast (FY)7.41
Revenue Forecast (FY)$408.34B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistent, multi-billion dollar operating and free cash flow provides durable financial flexibility. FCF coverage of earnings and stable OCF enable ongoing investment in care delivery, debt reduction, dividend support and tech/AI programs, cushioning the company through profit-cycle volatility.
Vertically Integrated Scale And Diversified RevenueLarge, diversified footprint across PBM, health benefits, retail pharmacy and care delivery creates structural advantages: cross-selling, negotiated purchasing scale, and lower unit costs. Scale smooths revenue volatility and supports durable competitive positioning in payer-provider integration.
Aetna Margin Recovery And Operational WinsMaterial YOY improvement at Aetna and lower MBR reflect better underwriting, utilization management and prior-authorization efficiencies. Sustainable improvement in insurance margins strengthens the enterprise's earnings power and validates care-management investments over the medium term.
Bears Say
Compressed Profitability And Weakened ReturnsSignificant margin compression and falling ROE indicate the business is earning much less on its asset and equity base than historically. Persistently low returns constrain reinvestment, slow deleveraging capacity, and reduce the long-term ability to generate excess shareholder value absent structural margin recovery.
PBM Rebate Guarantees And Client Price PressureStructural shifts in rebate contracting and client price concessions compress PBM spreads, a core earnings source. Reduced ability to retain manufacturer economics increases revenue volatility and makes long-term PBM profitability more sensitive to contract terms and regulatory change.
Regulatory And State-level UncertaintyFragmented state actions and evolving federal rules introduce sustained compliance, reimbursement and access risks for pharmacy and PBM operations. Ongoing legal and policy shifts can raise costs, limit fee schedules, and structurally alter revenue drivers across retail and PBM channels over multiple quarters.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $58.50 and its highest was $102.77 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $125.45B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Aug 05, 2026 which is in 45 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 06, 2026. The company reported $2.57 earnings per share for the quarter, beating the consensus estimate of $2.184 by $0.386.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 3.41%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.83.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,275,927,200 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $2.57 in its last earnings report, beating expectations of $2.184. Following the earnings report the stock price went up 7.647%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$104.53 (35.23% Upside)
$104.53 (35.23% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 18.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $323.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
52.47%
12-Months-Change
Fundamentals
Return on Equity
3.87%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corporation is a prominent healthcare services provider operating across the United States. The company's Health Care Benefits division delivers a range of health insurance offerings, including traditional plans, voluntary coverage, and consumer-directed options, alongside associated services. Its diverse clientele spans employer organizations, private individuals, university students, part-time and hourly staff, various health plans, healthcare providers, government bodies, state-sponsored programs, labor unions, and individuals living abroad. Through its Pharmacy Services segment, CVS Health manages pharmacy benefits, offering comprehensive solutions such as designing and administering plans, managing drug formularies, overseeing retail pharmacy networks, and providing mail-order, specialty pharmacy, and infusion services. This segment also delivers clinical support and helps manage disease and medical expenditures. It serves a broad array of clients, including employers, insurance carriers, trade unions, government employee groups, health plans, prescription drug programs, Medicaid managed care organizations, and plans available on both public and private health insurance marketplaces, in addition to other health benefit plan sponsors and individual consumers. Operationally, this segment encompasses specialty retail pharmacies, specialty mail-order services, general mail-order dispensing pharmacies, compounding pharmacies, and facilities dedicated to infusion and enteral nutrition support. The Retail/LTC (Long-Term Care) segment is responsible for selling both prescription and over-the-counter medications, consumer health and beauty items, and personal care products. It also delivers healthcare services via its MinuteClinic walk-in medical clinics. Furthermore, this segment handles the distribution of prescription drugs and offers pharmacy consulting along with other supplementary services to long-term care facilities and various other care environments. As of December 31, 2021, CVS Health boasted approximately 9,900 retail outlets and 1,200 MinuteClinic locations. This network is complemented by online retail pharmacy platforms, LTC pharmacies, and on-site pharmacies. Originally established in 1963 and headquartered in Woonsocket, Rhode Island, the company was known as CVS Caremark Corporation before officially rebranding to CVS Health Corporation in September 2014.
CVS Company Deck
CVS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone driven by clear top-line growth, strong cash generation, profit and EPS beats, an upward revision to full-year EPS guidance, meaningful improvement at Aetna (material AOI gain and operational efficiencies), and ongoing technology/AI initiatives (Health100). Offsetting risks include segment-level profit declines (Health Services and PCW), membership impacts from the Individual Exchange exit, continued elevated medical cost trends, PBM rebate pressures and regulatory/state-level uncertainty. On balance, the favorable operating metrics, raised guidance, and credible path to margin recovery outweighed the identifiable challenges.View all CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
$104.53
▲(35.23% Upside)
Technical Analysis
Ownership Overview
0.41% Insiders
32.84% Mutual Funds
26.06% Other Institutional Investors
16.81% Public Companies and Individual Investors